Cargando…

External validation of serum hCG cutoff levels for prediction of resistance to single-agent chemotherapy in patients with persistent trophoblastic disease

Van Trommel et al have previously shown that serum human chorionic gonadotropin (hCG) cutoff levels can provide early prediction of resistance to first-line methotrexate (MTX) in patients with persistent trophoblastic disease (PTD). In this study, we validate this approach of prediction of resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerkmeijer, L G, Thomas, C M, Harvey, R, Sweep, F C, Mitchell, H, Massuger, L F, Seckl, M J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661779/ https://www.ncbi.nlm.nih.gov/pubmed/19293810 http://dx.doi.org/10.1038/sj.bjc.6604849

Ejemplares similares

Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements
por: You, B, et al.
Publicado: (2013)

Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract
por: Douglas, J, et al.
Publicado: (2014)

Biological functions of hCG and hCG-related molecules
por: Cole, Laurence A
Publicado: (2010)

The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(−1)
por: McGrath, S, et al.
Publicado: (2010)

Hyperglycosylated-hCG: Its Role in Trophoblast Invasion and Intrauterine Growth Restriction
por: Herghelegiu, Catalin Gabriel, et al.
Publicado: (2023)

Validation of (125)I-hCG as a marker for elimination of hCG and stability of (125)I-hCG after in vivo injection in humans
por: Christensen, T B, et al.
Publicado: (1999)

(125)I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer
por: Christensen, T B, et al.
Publicado: (1999)

Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.
por: Mora, J., et al.
Publicado: (1996)

Can Pretreatment Serum Beta-hCG be Used for Predicting Thyrotoxicosis in Gestational Trophoblastic Disease?
por: Khomphaiboonkij, Uraiwan, et al.
Publicado: (2021)

Pituitary hCG production and cerebral tuberculosis mimicking disease progression during chemotherapy for an advanced ovarian germ cell tumour
por: Rakha, Serena, et al.
Publicado: (2010)

Independent and functional validation of a multi-tumour-type proliferation signature
por: Starmans, M H W, et al.
Publicado: (2012)

hCG, the wonder of today's science
por: Cole, Laurence A
Publicado: (2012)

Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
por: Chua, W, et al.
Publicado: (2009)

Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients
por: Jennings, C J, et al.
Publicado: (2015)

The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer
por: Beresford, M J, et al.
Publicado: (2006)

TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy
por: Oden-Gangloff, A, et al.
Publicado: (2009)

Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse
por: Lu, C-Y, et al.
Publicado: (2011)

Thoracotomy in refractory gestational trophoblastic neoplasia with lung metastasis after normalization of serum beta human chorionic gonadotropin (β-hCG) with salvage chemotherapy
por: Feng, Fengzhi, et al.
Publicado: (2014)

Beta-hCG expression by bladder cancers.
por: Iles, R.
Publicado: (1992)

hCG: Biological Functions and Clinical Applications
por: Nwabuobi, Chinedu, et al.
Publicado: (2017)

hCG Triggering in ART: An Evolutionary Concept
por: Hershko Klement, Anat, et al.
Publicado: (2017)

Efficacy of Oral Vitamin A in Reducing β-hCG Levels in Low-Risk Gestational Trophoblastic Neoplasia Patients
por: Hidayat, Yudi Mulyana, et al.
Publicado: (2020)

Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy
por: Oppenheim, D E, et al.
Publicado: (2014)

Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy
por: Kelly, P, et al.
Publicado: (2010)

Death-associated protein-3, DAP-3, correlates with preoperative chemotherapy effectiveness and prognosis of gastric cancer patients following perioperative chemotherapy and radical gastrectomy
por: Jia, Y, et al.
Publicado: (2014)

Determinants of the hCG Concentration in the Early Luteal Phase After Final Maturation of Follicles With Bolus Trigger of Recombinant hCG
por: Vuong, Lan N., et al.
Publicado: (2020)

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA
por: McKiernan, E, et al.
Publicado: (2008)

GnRH agonist in association with hCG versus hCG alone for final oocyte maturation triggering in GnRH antagonist cycles
por: de Oliveira Filho, Condesmar M., et al.
Publicado: (2021)

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
por: Bain, G H, et al.
Publicado: (2014)

Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis
por: Liu, W M, et al.
Publicado: (2012)

Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial
por: Decleer, W., et al.
Publicado: (2014)

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer
por: Darb-Esfahani, S, et al.
Publicado: (2012)

Cross-Talk between cAMP and MAPK Pathways in HSD11B2 Induction by hCG in Placental Trophoblasts
por: Shu, Qun, et al.
Publicado: (2014)

Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma
por: Miyagaki, H, et al.
Publicado: (2012)

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
por: Oikonomopoulou, K, et al.
Publicado: (2008)

Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer
por: Dotan, E, et al.
Publicado: (2012)

Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide
por: Young, R J, et al.
Publicado: (2012)

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer
por: Mahon, K L, et al.
Publicado: (2014)

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy
por: Manton, D J, et al.
Publicado: (2006)

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)
por: Pinato, D J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lg7l022oeeo9ffom318ilc5c7e